Vistra is initiated with a Hold rating and a $160.00 twelve-month price target. At 9.1 times 2027 enterprise value, strong capacity pricing and nuclear loan support are balanced by high debt and softening wholesale Texas power curves.
Key points
- $156.78 share price fully reflects Vistra's high hedge coverage and 2027 earnings growth, balancing AI power premiums against leverage.
- $1.30 billion in locked 2028/2029 PJM capacity auction revenues and a $4.20 billion conditional nuclear loan provide cash flow stability.
- $21.00 billion projected year-end 2027 net debt limits equity upside as Cogentrix closing and nuclear uprates absorb operating cash.
The call
Current pricing requires Vistra to generate $8.20 billion in 2027 ongoing adjusted EBITDA and trade at 9.1 times enterprise value, an elevated level for an independent power producer. The market assumes frictionless integration of Cogentrix, rapid execution of Meta power purchase contracts, and unconstrained nuclear uprates funded via conditional federal support.
Ongoing Operations Adjusted EBITDA ($ billions)SEC filings (2024-2025) and analyst forecasts (2026E-2027E) based on company guidance and expansion pipeline.
We believe the stock is about right. Near-term power output is 94% hedged for 2027, locking in cash flow, but wholesale power curve softening in Texas and substantial debt obligations temper further multiple expansion. Capital outlays for acquisitions and plant modernization leave little room for incremental shareholder distributions beyond existing repurchase authorizations.
Valuation Bridge: Enterprise Value to Target Equity Value ($ billions)Analyst valuation model walking enterprise value ($74.60B) to equity value ($53.60B) at $160.00 target.
Valuation
| Valuation metric | 2027 Projection |
|---|
| Ongoing Adjusted EBITDA | $8.20 billion |
| Target EV/EBITDA multiple | 9.10 times |
| Target enterprise value | $74.60 billion |
| Projected net debt (YE 2027) | $21.00 billion |
| Implied target equity value | $53.60 billion |
| Diluted share count | 335.0 million |
| 12-month price target | $160.00 per share |
A 9.1 times multiple reflects a balanced blend between stable, regulated-like contracted nuclear generation and cyclical merchant gas exposure. With upside limited to 2.1%, the risk-reward profile is symmetric, supporting a Hold rating as the shares track broader market returns.
Risks
- ERCOT power curve weakness: Softening wholesale power clearing prices in Texas could reduce unhedged merchant realization and lower forward hedging contracts.
- Financing and execution: The $4.20 billion nuclear loan commitment is conditional; failure to finalize binding terms would raise borrowing costs.
- M&A leverage: Closing the $2.30 billion cash and $1.50 billion debt Cogentrix transaction raises interest burdens in a sustained high-rate environment.
What would change my mind
We would turn positive if Vistra secures accretive long-term, behind-the-meter data center contracts across its entire merchant nuclear fleet at guaranteed double-digit cash margins.